Back to results
US 6,720,153 B1Granted
Luciferase reporter bioassay of parathyroid hormone compounds
AssigneeAventis Pharmaceuticals Inc.
InventorsRichard F. Labaudiniere, Kin T. Yu, Gregg R. Crumley, Clarence C. Morse
Life of this patent
Estimating the term…
Abstract
This invention is directed to a bioassay for determining the functionality of parathyroid hormone compounds. More particularly, this invention is directed to a bioassay wherein the compound to be tested is added to a culture of parathyroid hormone receptor expressing cells bearing a reporter gene under the transcriptional control of multiple c-AMP responsive elements.
Claims7
A method for determining the functionality of a parathyroid hormone compound, the method comprising
- (a) adding the compound to a culture of parathyroid hormone receptor expressing cells bearing a reporter gene under the transcriptional control of multiple cAMP responsive elements, and then measuring the expression of the reporter gene;
- and
- (b) comparing the measured expression of step (a) with the measured expression of the reporter gene in a control culture comprising:
- (i) the parathyroid hormone receptor expressing cells bearing the reporter gene under the transcriptional control of multiple cAMP response elements, and a parathyroid hormone, a parathyroid hormone-related protein, a parathyroid receptor agonist, or a combination thereof, or
- (ii) the parathyroid hormone receptor expressing cells bearing a reporter gene under the transcriptional control of multiple cAMP responsive elements, in the absence of the parathyroid hormone compound, wherein a difference between the measured expression of step (a) and the measured expression of the control culture is indicative of the functionality of the parathyroid hormone compound, and wherein the number of cAMP responsive elements is greater than about 10.
2 more elements
Dependencies are inferred from the claim text.